Vanguard Portfolio Management’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$364M Sell
1,972,645
-10,869
-0.5% -$2.36M 0.02% 824
2026
Q2
$486M Sell
1,983,514
-74,656
-4% -$16.2M 0.02% 728
2026
Q1
$348M Buy
+2,058,170
New +$356M 0.02% 816

Other funds holding AXSM

Vanguard Portfolio Management's AXSM Position: Q3 2026 in Review

Vanguard Portfolio Management reduced its Axsome Therapeutics (AXSM) stake by 0.55% in Q3 2026, selling an estimated $2.36M and leaving 1,972,645 shares worth $364M. The position accounts for 0.02% of the portfolio, ranked #824.

Vanguard Portfolio Management first reported a position in AXSM in Q1 2026 and has held it in 3 quarters since. The position peaked at $486M in Q2 2026. 348 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • Vanguard Portfolio Management held 1,972,645 shares of Axsome Therapeutics worth $364M as of Q3 2026.
  • Vanguard Portfolio Management sold 10,869 Axsome Therapeutics shares in Q3 2026, an estimated $2.36M.
  • Axsome Therapeutics made up 0.02% of Vanguard Portfolio Management's portfolio in Q3 2026, its #824 holding.
  • Vanguard Portfolio Management first reported a position in Axsome Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Portfolio Management's Axsome Therapeutics position peaked at $486M in Q2 2026.
  • 348 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.